Phreesia, Inc. (NYSE:PHR) General Counsel Allison C. Hoffman Sells 3,496 Shares

Phreesia, Inc. (NYSE:PHR - Get Free Report) General Counsel Allison C. Hoffman sold 3,496 shares of the firm's stock in a transaction that occurred on Tuesday, February 18th. The shares were sold at an average price of $29.72, for a total value of $103,901.12. Following the completion of the sale, the general counsel now directly owns 142,630 shares in the company, valued at approximately $4,238,963.60. The trade was a 2.39 % decrease in their ownership of the stock. The sale was disclosed in a document filed with the SEC, which is available through this link.

Phreesia Trading Down 3.8 %

Phreesia stock traded down $1.07 during trading on Monday, reaching $27.15. 399,788 shares of the company were exchanged, compared to its average volume of 386,314. Phreesia, Inc. has a 52-week low of $17.07 and a 52-week high of $30.53. The company has a market capitalization of $1.58 billion, a P/E ratio of -18.47 and a beta of 0.96. The company has a debt-to-equity ratio of 0.04, a current ratio of 1.74 and a quick ratio of 1.74. The stock's 50 day simple moving average is $27.32 and its two-hundred day simple moving average is $23.90.

Phreesia (NYSE:PHR - Get Free Report) last announced its quarterly earnings data on Monday, December 9th. The company reported ($0.25) EPS for the quarter, topping analysts' consensus estimates of ($0.29) by $0.04. Phreesia had a negative return on equity of 32.78% and a negative net margin of 20.43%. The firm had revenue of $106.80 million for the quarter, compared to the consensus estimate of $106.33 million. During the same quarter last year, the business posted ($0.58) earnings per share. The firm's revenue was up 16.6% compared to the same quarter last year. On average, equities research analysts expect that Phreesia, Inc. will post -1.1 earnings per share for the current fiscal year.

Institutional Investors Weigh In On Phreesia

Institutional investors and hedge funds have recently added to or reduced their stakes in the business. Johnson Financial Group Inc. raised its position in Phreesia by 381.3% in the fourth quarter. Johnson Financial Group Inc. now owns 1,131 shares of the company's stock valued at $28,000 after purchasing an additional 896 shares during the period. R Squared Ltd purchased a new stake in Phreesia in the fourth quarter valued at $30,000. International Assets Investment Management LLC raised its position in Phreesia by 2,179.7% in the third quarter. International Assets Investment Management LLC now owns 1,459 shares of the company's stock valued at $33,000 after purchasing an additional 1,395 shares during the period. BankPlus Trust Department purchased a new stake in Phreesia in the fourth quarter valued at $34,000. Finally, Quarry LP raised its position in Phreesia by 210.9% in the fourth quarter. Quarry LP now owns 2,835 shares of the company's stock valued at $71,000 after purchasing an additional 1,923 shares during the period. Hedge funds and other institutional investors own 92.10% of the company's stock.

Analysts Set New Price Targets

Several brokerages have commented on PHR. KeyCorp raised their price objective on Phreesia from $28.00 to $30.00 and gave the company an "overweight" rating in a report on Wednesday, January 8th. Truist Financial raised their target price on Phreesia from $31.00 to $34.00 and gave the company a "buy" rating in a research report on Wednesday, December 11th. Piper Sandler restated an "overweight" rating and issued a $33.00 target price (up previously from $31.00) on shares of Phreesia in a research report on Wednesday, January 29th. Robert W. Baird decreased their target price on Phreesia from $34.00 to $30.00 and set an "outperform" rating on the stock in a research report on Wednesday, December 11th. Finally, Needham & Company LLC restated a "buy" rating and issued a $29.00 target price on shares of Phreesia in a research report on Friday, January 10th. Thirteen equities research analysts have rated the stock with a buy rating, Based on data from MarketBeat.com, the stock currently has an average rating of "Buy" and an average target price of $31.15.

Phreesia Company Profile

Phreesia, Inc provides an integrated SaaS-based software and payment platform for the healthcare industry in the United States and Canada. The company offers access solutions that offers appointment scheduling system for online appointments, reminders, and referral tracking management; registration solution to automate patient self-registration; revenue cycle solution, which offer insurance-verification processes, point-of-sale payments applications, post-visit payment collection, and flexible payment options; and network connect solution to deliver clinically relevant content to patients.